Skip to main content
Responses to parliamentary questions

Question from Deputy Marie Sherlock - PQ 57883-25

Risdiplam (Evrysdi®) and Nusinersen (Spinraza®)


Documents

Summary

To ask the Minister for Health the steps she will take to engage with the market authorisation holders of medications (details supplied) to submit pricing and reimbursement applications for these drug treatments to commence in patients over 18 years of age who are diagnosed with spinal muscular atrophy; and if she will make a statement on the matter


This is a beta version - your feedback will help us to improve it